Moderna

IPO

Pioneering mRNA technology

Public · Cambridge, United States · Founded 2010 · $1.6B raised

Employees
1001–5000
Founded
2010
Business Model
B2B
Total Funding
$1.6B
Last Round
$500.0M Venture RoundFeb 2018
Rounds
6
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 8 investors for this company. The full record is or through the API.

About

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Founded in September 2010, the company pioneered the development of mRNA-based medicines, culminating in the Moderna COVID-19 vaccine (Spikevax). The company's pipeline spans 44 candidates including vaccines for influenza, RSV (Mresvia, FDA-approved 2024), HIV, and cancer (mRNA-4157 personalized cancer vaccine in partnership with Merck). Moderna operates manufacturing facilities in Massachusetts and employs approximately 4,800 people worldwide as of 2025.

Summary

Moderna is a Biotech company based in Cambridge, United States, founded in 2010. It has raised $1.6B in total across 6 rounds, most recently a $500.0M Venture Round in Feb 2018. Investors include Flagship Pioneering, Coalition for Epidemic Preparedness Innovations (CEPI) and Abu Dhabi Investment Authority.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPODec 2018
$604.0M

Sign up to see all 7 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Moderna on Indexed.vc
<a href="https://indexed.vc/companies/moderna"><img src="https://indexed.vc/api/badge/company/moderna" alt="Moderna on Indexed.vc" width="260" height="76" /></a>